Check out BioModels Amylin Liver NASH (AMLN) Model!

With an increasing need for translational preclinical NAFLD, NASH, and liver fibrosis models, BioModels is pleased to share our recent validation data from the amylin liver NASH (AMLN) model.  This model recapitulates many features of human disease, including steatosis and fibrosis. BioModels is ready to help you assess your therapeutic for the treatment of this extremely prevalent disease.

From an initial consultation to better understand the disease model and develop a study design, through study execution and data reporting/interpretation, BioModels is here to be your partner every step of the way. Click here to view additional AMLN NASH model information and representative data!

Back to All News